Medicine News and Research

RSS

Psychological trauma leaves a trail of damage in a child's brain, reveal scientists

Psychological trauma leaves a trail of damage in a child's brain, say scientists at the Stanford University School of Medicine and Lucile Packard Children's Hospital. Their new study gives the first direct evidence that children with symptoms of post-traumatic stress suffer poor function of the hippocampus, a brain structure that stores and retrieves memories. The research helps explain why traumatized children behave as they do and could improve treatments for these kids.

9 Dec 2009

TMZ and small molecule combination appears to lower tumor resistance

University of Florida researchers have found a way to use just a fraction of the normal dosage of a highly toxic, debilitating chemotherapy drug to achieve even better results against colon cancer cells.

9 Dec 2009

ACR Image Metrix named as industry leader by Life Science Leader magazine

ACR Image Metrix™, an imaging contract research organization (CRO) located in Philadelphia, Pennsylvania, is pleased to announce that Mehdi Adineh, Ph.D., scientific director of the imaging core laboratory of the American College of Radiology (ACR), has been named an industry leader by Life Science Leader magazine.

9 Dec 2009

Mozobil with chemotherapy may have a therapeutic impact on leukemic cells, reveals study

Genzyme Corporation announced today that a Phase 1/2 trial provided early clinical data suggesting that Mozobil (plerixafor injection) in combination with chemotherapy may offer a therapeutic impact on leukemic cells protected in bone marrow.

9 Dec 2009

CDC awards Case Western Reserve University School of Medicine $19.7M for TB research

John L. Johnson, M.D., Professor of Medicine at Case Western Reserve University School of Medicine and pulmonologist at University Hospitals Case Medical Center has been awarded a 10 year, $19.7M contract from the U.S. Centers for Disease Control and Prevention (CDC) as an international clinical trials site for the Tuberculosis Trials Consortium (TBTC).

9 Dec 2009

GSK updates long-term survival data of BEXXAR Therapeutic Regimen for Non-Hodgkin's lymphoma

GlaxoSmithKline announced today updated long-term survival data from two Phase II studies of BEXXAR® (tositumomab and iodine I-131 tositumomab) used in either patients with previously untreated cancer of the immune system (follicular lymphoma) or in patients with cancer of the lymphocytes (non-Hodgkin's lymphoma, NHL) that no longer responded to rituximab.

9 Dec 2009

Spine system: A new technique to treat lower back pain

Using a branch of science that crosses disciplines to study complex problems, a Michigan State University researcher is introducing a new way to understand and treat lower back pain, a condition affecting more than 40 million Americans and costing billions of dollars each year.

9 Dec 2009

Multi-institutional study identifies potential treatment target for ovarian cancer

A multi-institutional study has identified a potential personalized treatment target for the most common form of ovarian cancer. In the December 8 issue of Cancer Cell, the research team describes finding that a gene called MAGP2 - not previously associated with any type of cancer - was overexpressed in papillary serous ovarian tumors of patients who died more quickly. They also found evidence suggesting possible mechanisms by which MAGP2 may promote tumor growth.

9 Dec 2009

Tips to prevent hangover during holiday season

"Eating food is an important element in reducing drinking and reducing risk of intoxication," Garbutt said. Eat a meal before you take your first sip of alcohol, he advises, and continue to take in food as the night wears on. Food, fats especially, help slow down the body's absorption of alcohol. But to truly be effective, the food must be in your stomach first. If you wait until you're feeling buzzed or tipsy to start eating, it's already too late.

9 Dec 2009

New breakthrough study shows reconstruction of human mandible bone with dental stem cells

In a statement today, StemSave(TM), Inc., the market leader in the field of stem cell recovery and cryo-preservation lauds research published in the November issue of the European Cells and Materials Journal citing the reconstruction of the human mandible bone with autologous dental pulp stem cells.

9 Dec 2009

Soy food associated with lower risk of death and breast cancer recurrence, says new study

Researchers at Vanderbilt-Ingram Cancer Center, led by Xiao Ou Shu, M.D., Ph.D., professor of Medicine, have found that a higher intake of soy foods was associated with a lower risk of death and breast cancer recurrence among breast cancer patients in China. The study is published in the December 9 issue of JAMA.

9 Dec 2009

National Institute on Aging awards grant to study age-related brain disorders

Dr. Rong Zhang, a researcher at the Institute for Exercise and Environmental Medicine at Texas Health Presbyterian Hospital Dallas, has been awarded a four-year grant from the National Institute on Aging to research the connection between exercise and brain function as people age.

9 Dec 2009

Combination of gene and cell therapy improves critical limb ischemia associated with aging or diabetes

Blood vessel blockage, a common condition in old age or diabetes, leads to low blood flow and results in low oxygen, which can kill cells and tissues. Such blockages can require amputation resulting in loss of limbs. Now, using mice as their model, researchers at Johns Hopkins have developed therapies that increase blood flow, improve movement and decrease tissue death and the need for amputation.

8 Dec 2009

CDC awards $19.7 million contract to study new drugs for tuberculosis treatment

8 Dec 2009

House Democrats criticize recent increases in brand-name drug prices

The Wall Street Journal: "Reports of prescription drug-price increases have congressional Democrats complaining about price gouging and questioning whether drug companies are reneging on a pledge to provide billions of savings as part of a U.S. health-care overhaul sought by President Barack Obama.

8 Dec 2009

MCG receives $1.8M stimulus grant

It's a $1.8 million shot in the arm to the largest grant the Medical College of Georgia has ever received.

8 Dec 2009

Acesis Performance Improvement Platform provides digital performance assessment capabilities for hospitals

Acesis, the enterprise software firm, headquartered in Silicon Valley and focused on healthcare, today announced its expanded technology solution, the Acesis Performance Improvement Platform that provides hospitals digital performance assessment capabilities that can be easily set up for each hospital’s unique vision of quality care.

8 Dec 2009

Today's opinions and editorials

As a society, we have to make choices. Do we want our doctors to be well-qualified practitioners using their experience and judgment to help as many patients as they can? Or do we want detached, disenfranchised doctors looking to their next career while practicing medicine with the mentality of postal workers? (Soumi Eachempati 12/7).

8 Dec 2009

Three university academic groups sponsored for the MetaMiner project

GeneGo, Inc., the leading systems biology tools company, announced today that Millipore Corporation has sponsored academic groups from University of Queensland, Sheffield and USC to become members of the collaborative MetaMiner (Stem Cells) project run by GeneGo. MetaMiner is a partnership program for the reconstruction of stem cell pathways and their application in analysis of experimental data as well as knowledge mining.

8 Dec 2009

Encouraging results from Semafore Pharmaceuticals' SF1126 Phase I dose-escalation trial for myeloma

Semafore Pharmaceuticals today reported encouraging data from a Phase I dose-escalation trial of SF1126 in patients with relapsed and refractory myeloma. SF1126 is a novel small molecule inhibitor of phosphoinositide-3-kinase (PI3K) and mammalian target of rapamycin (mTOR), two key members of the PI3K signaling pathway that is vital to several essential biological processes, such as cell proliferation and survival. PI3K is commonly altered in human cancers, making inhibition of the target attractive for cancer therapy.

8 Dec 2009

Medicine News and Research

Psychological trauma leaves a trail of damage in a child's brain, reveal scientists

TMZ and small molecule combination appears to lower tumor resistance

ACR Image Metrix named as industry leader by Life Science Leader magazine

Mozobil with chemotherapy may have a therapeutic impact on leukemic cells, reveals study

CDC awards Case Western Reserve University School of Medicine $19.7M for TB research

GSK updates long-term survival data of BEXXAR Therapeutic Regimen for Non-Hodgkin's lymphoma

Spine system: A new technique to treat lower back pain

Multi-institutional study identifies potential treatment target for ovarian cancer

Tips to prevent hangover during holiday season

New breakthrough study shows reconstruction of human mandible bone with dental stem cells

Soy food associated with lower risk of death and breast cancer recurrence, says new study

National Institute on Aging awards grant to study age-related brain disorders

Combination of gene and cell therapy improves critical limb ischemia associated with aging or diabetes

CDC awards $19.7 million contract to study new drugs for tuberculosis treatment

House Democrats criticize recent increases in brand-name drug prices

MCG receives $1.8M stimulus grant

Acesis Performance Improvement Platform provides digital performance assessment capabilities for hospitals

Today's opinions and editorials

Three university academic groups sponsored for the MetaMiner project

Encouraging results from Semafore Pharmaceuticals' SF1126 Phase I dose-escalation trial for myeloma

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News